177 related articles for article (PubMed ID: 18026163)
21. Carbamyl phosphate synthetase I. A novel marker for gastric carcinoma.
Liu TH; Li DC; Gu CF; Ye SF
Chin Med J (Engl); 1989 Aug; 102(8):630-8. PubMed ID: 2517620
[TBL] [Abstract][Full Text] [Related]
22. Understanding carbamoyl phosphate synthetase (CPS1) deficiency by using the recombinantly purified human enzyme: effects of CPS1 mutations that concentrate in a central domain of unknown function.
Díez-Fernández C; Hu L; Cervera J; Häberle J; Rubio V
Mol Genet Metab; 2014 Jun; 112(2):123-32. PubMed ID: 24813853
[TBL] [Abstract][Full Text] [Related]
23. Role of Hepatocyte Paraffin 1 antigen in the course of colorectal carcinogenesis.
Abu-Zeid RM; Farid RM
Int J Physiol Pathophysiol Pharmacol; 2013; 5(3):177-83. PubMed ID: 24044037
[TBL] [Abstract][Full Text] [Related]
24. Immunoreactivity of hepatocyte paraffin 1 monoclonal antibody in cutaneous metastatic tumors.
Kanitakis J; Chouvet B; Claudy A; Scoazec JY
Am J Clin Pathol; 2004 Jul; 122(1):85-9. PubMed ID: 15272534
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical characterization of canine hyperplastic hepatic lesions and hepatocellular and biliary neoplasms with monoclonal antibody hepatocyte paraffin 1 and a monoclonal antibody to cytokeratin 7.
Ramos-Vara JA; Miller MA; Johnson GC
Vet Pathol; 2001 Nov; 38(6):636-43. PubMed ID: 11732796
[TBL] [Abstract][Full Text] [Related]
26. Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma.
Çeliktas M; Tanaka I; Tripathi SC; Fahrmann JF; Aguilar-Bonavides C; Villalobos P; Delgado O; Dhillon D; Dennison JB; Ostrin EJ; Wang H; Behrens C; Do KA; Gazdar AF; Hanash SM; Taguchi A
J Natl Cancer Inst; 2017 Mar; 109(3):1-9. PubMed ID: 28376202
[TBL] [Abstract][Full Text] [Related]
27. Ornithine aminotransferase and carbamoyl phosphate synthetase 1 involved in ammonia metabolism serve as novel targets for early stages of gastric cancer.
Jiang Z; Wei C; Luo Y; Xiao Y; Wang L; Guo W; Yuan X
J Clin Lab Anal; 2022 Oct; 36(10):e24692. PubMed ID: 36098904
[TBL] [Abstract][Full Text] [Related]
28. Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency.
Martínez AI; Pérez-Arellano I; Pekkala S; Barcelona B; Cervera J
Mol Genet Metab; 2010 Dec; 101(4):311-23. PubMed ID: 20800523
[TBL] [Abstract][Full Text] [Related]
29. Split AAV-Mediated Gene Therapy Restores Ureagenesis in a Murine Model of Carbamoyl Phosphate Synthetase 1 Deficiency.
Nitzahn M; Allegri G; Khoja S; Truong B; Makris G; Häberle J; Lipshutz GS
Mol Ther; 2020 Jul; 28(7):1717-1730. PubMed ID: 32359471
[TBL] [Abstract][Full Text] [Related]
30. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections.
Fan Z; van de Rijn M; Montgomery K; Rouse RV
Mod Pathol; 2003 Feb; 16(2):137-44. PubMed ID: 12591966
[TBL] [Abstract][Full Text] [Related]
31. Carbamoyl phosphate synthetase 1 (CPS1) as a prognostic marker in chronic hepatitis C infection.
El-Sheikh RM; Mansy SS; Nessim IG; Hosni HN; El Hindawi A; Hassanein MH; AbdelFattah AS
APMIS; 2019 Feb; 127(2):93-105. PubMed ID: 30698308
[TBL] [Abstract][Full Text] [Related]
32. Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency.
Choi Y; Oh A; Lee Y; Kim GH; Choi JH; Yoo HW; Lee BH
Clin Chim Acta; 2022 Feb; 526():55-61. PubMed ID: 34973183
[TBL] [Abstract][Full Text] [Related]
33. Prenatal diagnosis of carbamoyl phosphate synthetase I deficiency by identification of a missense mutation in CPS1.
Finckh U; Kohlschütter A; Schäfer H; Sperhake K; Colombo JP; Gal A
Hum Mutat; 1998; 12(3):206-11. PubMed ID: 9711878
[TBL] [Abstract][Full Text] [Related]
34. Recurrence of carbamoyl phosphate synthetase 1 (CPS1) deficiency in Turkish patients: characterization of a founder mutation by use of recombinant CPS1 from insect cells expression.
Hu L; Diez-Fernandez C; Rüfenacht V; Hismi BÖ; Ünal Ö; Soyucen E; Çoker M; Bayraktar BT; Gunduz M; Kiykim E; Olgac A; Pérez-Tur J; Rubio V; Häberle J
Mol Genet Metab; 2014 Dec; 113(4):267-73. PubMed ID: 25410056
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of carbamoyl-phosphate synthase 1 significantly improves ureagenesis of human liver HepaRG cells only when cultured under shaking conditions.
Adam AAA; van der Mark VA; Ruiter JPN; Wanders RJA; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
Mitochondrion; 2019 Jul; 47():298-308. PubMed ID: 30802674
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of carbamoyl-phosphate synthetase (CPS1) deficiency using human recombinant CPS1 as a key tool.
Diez-Fernandez C; Martínez AI; Pekkala S; Barcelona B; Pérez-Arellano I; Guadalajara AM; Summar M; Cervera J; Rubio V
Hum Mutat; 2013 Aug; 34(8):1149-59. PubMed ID: 23649895
[TBL] [Abstract][Full Text] [Related]
37. Network Analysis of Metabolite GWAS Hits: Implication of CPS1 and the Urea Cycle in Weight Maintenance.
Matone A; Scott-Boyer MP; Carayol J; Fazelzadeh P; Lefebvre G; Valsesia A; Charon C; Vervoort J; Astrup A; Saris WH; Morine M; Hager J
PLoS One; 2016; 11(3):e0150495. PubMed ID: 26938218
[TBL] [Abstract][Full Text] [Related]
38. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study.
Villari D; Caruso R; Grosso M; Vitarelli E; Righi M; Barresi G
Pathology; 2002 Oct; 34(5):423-6. PubMed ID: 12408340
[TBL] [Abstract][Full Text] [Related]
39. Ammonia-lowering activities and carbamoyl phosphate synthetase 1 (Cps1) induction mechanism of a natural flavonoid.
Nohara K; Shin Y; Park N; Jeong K; He B; Koike N; Yoo SH; Chen Z
Nutr Metab (Lond); 2015; 12():23. PubMed ID: 26075008
[TBL] [Abstract][Full Text] [Related]
40. SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle.
Nakagawa T; Lomb DJ; Haigis MC; Guarente L
Cell; 2009 May; 137(3):560-70. PubMed ID: 19410549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]